Facebook
Twitter
LinkedIn
ForwardPatrick Loehrer, M.D.
Patrick J. Loehrer, Sr., M.D. is the Joseph W. and Jackie J. Cusick Professor in Oncology and Distinguished Professor of Indiana University. He is also the Director of the IUSCCC Center for Global Oncology and Health Equities. He has been an active clinical researcher and specialist in the treatment of a variety of cancers including testis, bladder, colon, pancreas and, most notably, thymic malignancies. His research on the drug, ifosfamide, led to its approval by the FDA. Dr. Loehrer is also the founding director of the Academic Model for Providing Access to Healthcare (AMPATH)-Oncology Program for over the past decade, which now sees over 8,000 cancer patients a year and screens over 1,500 women for cervical and breast cancers a month in western Kenya. He is co-PI on a U54 grant studying the long-term impact of HPV in HIV infected and uninfected women in Kenya and Uganda. Dr. Loehrer was the founding chair of the Hoosier Oncology Group (now Hoosier Cancer Research Network) for two decades, which has enrolled over 5,000 patients and conducted trials in 20 countries around the world. Dr. Loehrer has served on numerous boards and committees such as the FDA Oncology Drug Advisory Committee and chair of the NCI Clinical Trials Advisory Committee. Dr. Loehrer is director emeritus of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, an NCI-designated Cancer Center and led the efforts to achieve comprehensive status in 2019. Dr. Loehrer has received numerous awards including the inaugural Allen S. Lichter Visionary Leader Award, and the 2023 Humanitarian Award from the American Society of Clinical Oncology.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:09/27/2024Date updated:09/27/2024